Analyst Reco. Eli Lilly and Company London S.E.

Equities

LEL

US5324571083

Market Closed - London S.E. Other stock markets 14:37:36 10/12/2021 GMT			5-day change	1st Jan Change
225.3 ^CHF	-1.50%		-58.28%	-58.28%

06-28	Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study	MT
06-28	EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	RE

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ANALYST RECOMMENDATIONS : Capri Holdings, Adobe, Broadcom, Celanese, Admiral...	06-25
Truist Adjusts Price Target on Eli Lilly & Co. to $1,000 From $892 After Model Update, Maintains Buy Rating	06-25	MT
Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update	06-24	DJ
Jefferies Adjusts Price Target on Eli Lilly to $1,015 From $994	06-24	MT
BIOGEN EXEC SAYS THE ALZHEIMER'S DRUG MARKET "WILL DEVELOP FASTE…	06-12	RE
Social Buzz: Wallstreetbets Stocks Mixed Premarket Wednesday; Oracle to Advance, AST SpaceMobile to Open Lower	06-12	MT
Jefferies Adjusts Price Target on Eli Lilly and Co. to $994 From $957	06-11	MT
Jefferies Adjusts Price Target on Eli Lilly to $957 From $925	06-07	MT
Goldman Sachs Adjusts Price Target on Eli Lilly to $785 From $740	05-30	MT
Jefferies Adjusts Price Target on Eli Lilly to $925 From $915	05-23	MT
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell; Hims & Hers Health to Advance, AMC Entertainment to Decline	05-21	MT
Argus Adjusts Price Target on Eli Lilly to $840 From $770	05-14	MT
Redburn Atlantic Adjusts Eli Lilly Price Target to $600 From $540	05-14	MT
China Merchants Initiates Eli Lilly at Buy Rating With $852 Price Target	05-08	MT
JPMorgan Adjusts Price Target on Eli Lilly to $900 From $850	05-01	MT
Wolfe Research Adjusts Price Target on Eli Lilly to $909 From $813	05-01	MT
Barclays Adjusts Price Target on Eli Lilly and Company to $913 From $810	05-01	MT
BMO Capital Adjusts Eli Lilly Price Target to $1,001 From $900	05-01	MT
Leerink Partners Adjusts Price Target on Eli Lilly to $901 From $821	05-01	MT
Deutsche Bank Adjusts Price Target on Eli Lilly to $725 From $695	05-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 06:47 pm